Effects of atrioventricular nodal ablation on permanent atrial fibrillation patients with cardiac resynchronization therapy: A systematic review and meta-analysis

Clinical Cardiology

Volumn 37, Issue 11, 2014, Pages 707-715

  Yin, Jie ^a,b   Hu, Hesheng ^a   Wang, Ye ^a   Xue, Mei ^a   Li, Xiaolu ^a   Cheng, Wenjuan ^a   Li, Xinran ^a   Yan, Suhua ^a  

^a Key Laboratory of Cardiovascular Proteomics of Shandong Province   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT;

ABLATION THERAPY; ATRIOVENTRICULAR NODAL ABLATION; BIBLIOGRAPHIC DATABASE; CARDIAC PATIENT; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR MORTALITY; CLINICAL EFFECTIVENESS; COHORT ANALYSIS; EVIDENCE BASED MEDICINE; EXERCISE; FUNCTIONAL STATUS; GENERAL CONDITION IMPROVEMENT; HEART ATRIUM FIBRILLATION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE REMODELING; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; LOW RISK PATIENT; META ANALYSIS; NEW YORK HEART ASSOCIATION CLASS; OBSERVATIONAL STUDY; PATIENT SELECTION; QUALITY OF LIFE; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TREATMENT RESPONSE; ATRIAL FIBRILLATION; CATHETER ABLATION; EXERCISE TEST; HEART ATRIOVENTRICULAR NODE; HEART STROKE VOLUME; SURGERY;

ATRIAL FIBRILLATION; ATRIOVENTRICULAR NODE; CARDIAC RESYNCHRONIZATION THERAPY; CATHETER ABLATION; EXERCISE TEST; HUMANS; QUALITY OF LIFE; STROKE VOLUME;

EID: 84912565476     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.22312     Document Type: Review

References (36)

1. Dickstein K, Vardas PE, Auricchio A, et al. 2010 Focused Update of ESC guidelines on device therapy in heart failure. An update of the 2008 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Europace. 2010;12:1526-1536.
2. McMurray JJ, Adamopoulos S, Anker SD, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure; 2012 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure; 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33:1787-1847.
3. Cleland JG, Daubert J-C, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-1549.
4. Daubert JC. Introduction to atrial fibrillation and heart failure: a mutually noxious association. Europace. 2003;5(suppl 1):S1-S4.
5. Delnoy PP, Ottervanger JP, Luttikhuis HO, et al. Comparison of usefulness of cardiac resynchronization therapy in patients with atrial fibrillation and heart failure versus patients with sinus rhythm and heart failure. Am J Cardiol. 2007;99:1252-1257.
6. Ferreira AM, Adragao P, Cavaco DM, et al. Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation. Europace. 2008;10:809-815.
7. Gasparini M, Auricchio A, Metra M, et al. Long-term survival in patients undergoing cardiac resynchronization therapy: the importance of performing atrio-ventricular junction ablation in patients with permanent atrial fibrillation. Eur Heart J. 2008;29:1644-1652.
8. Gasparini M, Auricchio A, Regoli F, et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. J Am Coll Cardiol. 2006;48:734-743.
9. Himmel F, Reppel M, Mortensen K, et al. A strategy to achieve CRT response in permanent atrial fibrillation without obligatory atrioventricular node ablation. Pacing Clin Electrophysiol. 2012;35:943-947.
10. Leclercq C, Victor F, Alonso C, et al. Comparative effects of permanent biventricular pacing for refractory heart failure in patients with stable sinus rhythm or chronic atrial fibrillation. Am J Cardiol. 2000;85:1154-1156.
11. Molhoek SG, Bax JJ, Bleeker GB, et al. Comparison of response to cardiac resynchronization therapy in patients with sinus rhythm versus chronic atrial fibrillation. Am J Cardiol. 2004;94:1506-1509.
12. Schutte F, Ludorff G, Grove R, et al. Atrioventricular node ablation is not a prerequisite for cardiac resynchronization therapy in patients with chronic atrial fibrillation. Cardiol J. 2009;16:246-249.
13. Tolosana JM, Arnau AM, Madrid AH, et al. Cardiac resynchronization therapy in patients with permanent atrial fibrillation. Is it mandatory to ablate the atrioventricular junction to obtain a good response? Eur J Heart Fail. 2012;14:635-641.
14. Tolosana JM, Trucco E, Khatib M, et al. Complete atrioventricular block does not reduce long-term mortality in patients with permanent atrial fibrillation treated with cardiac resynchronization therapy. Eur J Heart Fail. 2013;15:1412-1418.
15. Upadhyay GA, Choudhry NK, Auricchio A, et al. Cardiac resynchronization in patients with atrial fibrillation: a meta-analysis of prospective cohort studies. J Am Coll Cardiol. 2008;52:1239-1246.
16. Wilton SB, Leung AA, Ghali WA, et al. Outcomes of cardiac resynchronization therapy in patients with versus those without atrial fibrillation: a systematic review and meta-analysis. Heart Rhythm. 2011;8:1088-1094.
17. Mullens W, Grimm RA, Verga T, et al. Insights from a cardiac resynchronization optimization clinic as part of a heart failure disease management program. J Am Coll Cardiol. 2009;53:765-773.
18. Ritter P, Padeletti L, Gillio-Meina L, et al. Determination of the optimal atrioventricular delay in DDD pacing comparison between echo and peak endocardial acceleration measurements. Europace. 1999;1:126-130.
19. Hayes DL, Boehmer JP, Day JD, et al. Cardiac resynchronization therapy and the relationship of percent biventricular pacing to symptoms and survival. Heart Rhythm. 2011;8:1469-1475.
20. Wilton SB, Fundytus A, Ghali WA, et al. Meta-analysis of the effectiveness and safety of catheter ablation of atrial fibrillation in patients with versus without left ventricular systolic dysfunction. Am J Cardiol. 2010;106:1284-1291.
21. Koplan BA, Kaplan AJ, Weiner S, et al. Heart failure decompensation and all-cause mortality in relation to percent biventricular pacing in patients with heart failure. Is a goal of 100% biventricular pacing necessary? J Am Coll Cardiol. 2009;53:355-360.
22. Dong K, Shen WK, Powell BD, et al. Atrioventricular nodal ablation predicts survival benefit in patients with atrial fibrillation receiving cardiac resynchronization therapy. Heart Rhythm. 2010;7:1240-1245.
23. Jedrzejczyk-Patej J, Lenarczyk R, Kowalski O, et al. Atrioventricular junction ablation in patients with heart failure and atrial fibrillation treated with cardiac resynchronization therapy. Eur Heart J. 2010;31(suppl):418.
24. Tolosana JM, Hernandez Madrid A, Brugada J, et al. Comparison of benefits and mortality in cardiac resynchronization therapy in patients with atrial fibrillation versus patients in sinus rhythm (Results of the Spanish Atrial Fibrillation and Resynchronization [SPARE] Study). Am J Cardiol. 2008;102:444-449.
25. Eisen A, Nevzorov R, Goldenberg G, et al. Cardiac resynchronization therapy in patients with atrial fibrillation: a 2-year follow-up study. Pacing Clin Electrophysiol. 2013;36:872-877.
26. Jedrzejczyk-Patej E, Lenarczyk R, Pruszkowska P et al. Long-term outcomes of cardiac resynchronization therapy are worse in patients who require atrioventricular junction ablation for atrial fibrillation than in those with sinus rhythm. Cardiology journal 2013;21(3):309-15.
27. Hayden JA, Cote P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med. 2006;144:427-437.
28. Roy D, Talajic M, Nattel S, et al. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med. 2008;358:2667-2677.
29. Healey JS, Hohnloser SH, Exner DV, et al. Cardiac resynchronization therapy in patients with permanent atrial fibrillation: results from the Resynchronization for Ambulatory Heart Failure Trial (RAFT). Circ Heart Fail. 2012;5:566-570.
30. Kamath GS, Cotiga D, Koneru JN, et al. The utility of 12-lead Holter monitoring in patients with permanent atrial fibrillation for the identification of nonresponders after cardiac resynchronization therapy. J Am Coll Cardiol. 2009;53:1050-1055.
31. Ganesan AN, Brooks AG, Roberts-Thomson KC, et al. Role of AV nodal ablation in cardiac resynchronization in patients with coexistent atrial fibrillation and heart failure a systematic review. J Am Coll Cardiol. 2012;59:719-726.
32. Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352:225-237.
33. Rathore SS, Curtis JP, Wang Y, et al. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA. 2003;289:871-878.
34. Calkins H, Yong P, Miller JM, et al. Catheter ablation of accessory pathways, atrioventricular nodal reentrant tachycardia, and the atrioventricular junction: final results of a prospective, multicenter clinical trial. The Atakr Multicenter Investigators Group. Circulation. 1999;99:262-270.
35. Hess PL, Jackson KP, Hasselblad V, et al. Is cardiac resynchronization therapy an antiarrhythmic therapy for atrial fibrillation? A systematic review and meta-analysis. Curr Cardiol Rep. 2013;15:330.
36. Gasparini M, Regoli F, Galimberti P, et al. Cardiac resynchronization therapy in heart failure patients with atrial fibrillation. Europace. 2009;11(suppl 5):v82-v86.